Analyst ratings can significantly influence investor sentiment and stock prices. The majority of bullish ratings for Y-mAbs Therapeutics suggests a positive outlook for the company, which could drive its stock price up. Additionally, the increased average price target indicates that analysts see potential for growth in the company's stock price.